Disclaimer

The alfapump® system is currently not approved in Canada for commercial use. DSR® therapy is still in development and is currently not approved in the United States or Canada. Any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed. Sequana Medical makes no claims of safety or effectiveness of the DSR® therapy in the U.S. or Canada. There is no link between the DSR® therapy and ongoing investigations with the alfapump® system in Europe, the United States or Canada.

Demonstrating the impact of alfapump® therapy

Through our ongoing development work and close collaboration with clinicians, we continue to grow the body of evidence of our alfapump® platform, as shown by the multiple peer-reviewed journal publications.

Physician interviews

Leading physicians talk about their experience with the alfapump®.

Patient stories

Patients that have been implanted with the alfapump® report about their significant improvement in their daily life.